Serial ultra‐deep sequencing of circulating tumor DNA reveals the clonal evolution in non‐small cell lung cancer patients treated with anti‐PD1 immunotherapy

BACKGROUND: Immune‐therapy with anti‐PD1 inhibitors, such as pembrolizumab, is revolutionizing the treatment of non‐small cell lung cancers (NSCLC). However, identifying patients for the potential therapeutic response and predicting therapy resistance and early relapse remains a challenge. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Wang, Yubo, Shi, Weiwei, Zhu, Mengxiao, Liu, Zhulin, Luo, Nuo, Zeng, Yanwu, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912064/
https://www.ncbi.nlm.nih.gov/pubmed/31692284
http://dx.doi.org/10.1002/cam4.2632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912064/
https://www.ncbi.nlm.nih.gov/pubmed/31692284
http://dx.doi.org/10.1002/cam4.2632

Ejemplares similares